-
kidney disease (CKD). It is
taken by mouth. The drug was
developed by
FibroGen, in
partnership with AstraZeneca. The most
common side
effects include...
-
along with
others from Linköping University, the
University of Ottawa,
FibroGen Inc., and
Synsam Opticians parti****ted in a
study on the
partial success...
- and has not yet been commercialised. The drug was
developed jointly by
FibroGen and AstraZeneca.
Unlike EPO,
which directly stimulates the
production of...
-
results in an
increase in
endogenous production of erythropoietin. Both
FibroGen compounds made it
through to
Phase II
clinical trials, but
these were suspended...
-
connective tissue growth factor (CTGF) protein. This drug was
developed by
FibroGen, Inc.
World Health Organization (2015). "International
Nonproprietary Names...
- has been
shown to have a role in
bacterial adhesion to host
cells and
fibrogen-binding qualities. In
experiments with
mutant strains of the C. diphtheriae...
-
Pharmacia AB,
later Pharmacia & Upjohn,
acquired by
Pfizer FF –
Fujifilm FG –
FibroGen FK –
Fermentek FPI –
Fusion Pharmaceuticals FS – F-star G – J. R. Geigy...
- Gemfibrozil, sold
under the
brand name
Lopid among others, is a
medication used to
treat abnormal blood lipid levels. It is
generally less
preferred than...
-
Thermo Fibrotek,
which changed its name to
Kadant at the same time; the
Fibrogen division was
renamed to
Kadant Composites at the same time. The granule...
- is
owned by
Energy Power Resources (EPR) and
operated by its
subsidiary Fibrogen.
After the BSE
crisis in the 1980s,
millions of
cattle were slaughtered...
